MeaTech received net proceeds from this offering of approximately $21.9 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by MeaTech. MeaTech intends to use the net proceeds from this offering to advance its program to develop commercial technologies to manufacture alternative foods, including potential acquisitions of other companies whose technologies are complementary or synergistic to its own, and for general corporate purposes, including working capital requirements.
Despite the decline in recent weeks, Beyond Meat stock remains dearly valued at a price-to-sales ratio of close to 40 based on this year’s expected revenue. This valuation puts it in a league with start-up biotech stocks and some high-priced cloud stocks. Media coverage continues to be overwhelmingly positive for Beyond Meat and its rival Impossible Foods, indicating that the outstanding growth they’ve seen lately should continue at least for the immediate future, but the valuation concerns aren’t going away anytime soon.